3B Blackbio DX Ltd Financials

3B Blackbio DX Ltd Financial Statement

3B Blackbio DX Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	30	21.18	26.13
Operating Expense	11.48	7.17	11.83
Net Profit	14.14	10.73	9.06
Net Profit Margin	47.13	50.66	34.67
Earning Per Share	16.51	12.53	10.57
EBIDTA	18.52	14.02	12.92
Effective Tax Rate	22.30	21.83	24.83

Particulars	Sep 2024
Revenue	30.00
Operating Expense	11.48
Net Profit	14.14
Net Profit Margin	47.13
Earning Per Share	16.51
EBIDTA	18.52
Effective Tax Rate	22.30

3B Blackbio DX Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	70.72	59.34	15.52
Operating Expenses Annual	35.62	29.76	16.76
Operating Profit Annual	47.43	36.84	8.86
Interest Annual	0.11	0.20	0.11
Depreciation	0.87	0.80	0.29
Net Profit Annual	34.21	26.42	8.01
Tax Annual	12.23	9.42	0.46

Particulars	Mar 2024
Total Revenue Annual	70.72
Operating Expenses Annual	35.62
Operating Profit Annual	47.43
Interest Annual	0.11
Depreciation	0.87
Net Profit Annual	34.21
Tax Annual	12.23

3B Blackbio DX Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	50.35	39.89	1.71
Cash Flow from Operations	28.47	21.16	7.98
Cash Flow from Investing	-20.32	-7.80	-1.52
Cash Flow from Financing	-3.62	-2.89	-6.31
Cash Flow at the End	54.88	50.35	1.85

Particulars	Mar 2024
Cash Flow at the Beginning	50.35
Cash Flow from Operations	28.47
Cash Flow from Investing	-20.32
Cash Flow from Financing	-3.62
Cash Flow at the End	54.88

3B Blackbio DX Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	67.05	62.08	57.09
PBIT Margin (%)	65.82	60.73	55.22
PBT Margin (%)	-532.57	-242.94	-447.36
Net PROFIT Margin (%)	48.37	44.52	51.61
Return On Networth / Equity (%)	16.14	24.01	34.39
Return On Networth /Employed (%)	21.82	32.09	33.57
Return On Assets (%)	15.96	23.60	31.48
Total Debt / Equity (X)	0.01	0.02	0.10
Asset Turnover Ratio (%)	0.33	0.53	0.61

Particulars	Mar 2024
PBDIT Margin (%)	67.05
PBIT Margin (%)	65.82
PBT Margin (%)	-532.57
Net PROFIT Margin (%)	48.37
Return On Networth / Equity (%)	16.14
Return On Networth /Employed (%)	21.82
Return On Assets (%)	15.96
Total Debt / Equity (X)	0.01
Asset Turnover Ratio (%)	0.33

3B Blackbio DX Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	6.53	6.79	3.23
Total Current Assets Annual	115.59	104.46	24.40
Non Current Assets Annual	134.23	109.21	7.20
Total Shareholders Funds Annual	227.78	196.09	23.93
Total Assets Annual	249.82	213.67	31.60

Particulars	Mar 2024
Fixed Assets Annual	6.53
Total Current Assets Annual	115.59
Non Current Assets Annual	134.23
Total Shareholders Funds Annual	227.78
Total Assets Annual	249.82

3B Blackbio DX Ltd Earning Calls

EPS (INR)

Expected

17.09

Reported

17.35

Surprise

1.52%

Jun 2024

EPS beaten by 1.52%

Mar 2024

EPS beaten by 1.54%

Dec 2023

EPS beaten by -0.87%

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, 3B Blackbio DX Ltd has a market capitalization of 660.52 Cr. Value Research classifies it as a Small-Cap company.

Yes, 3B Blackbio DX Ltd is debt-free with a debt-to-equity ratio of 0.00.

In FY 2023 , 3B Blackbio DX Ltd recorded a total revenue of approximately 70.72 Cr marking a significant milestone in the company's financial performance.

3B Blackbio DX Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.8% annually, respectively..

3B Blackbio DX Ltd's current PE ratio is 19.31.

3B Blackbio DX Ltd's ROCE averaged 23.7% from the FY ending March 2022 to 2024, with a median of 20.4%. It peaked at 32.4% in March 2022, reflecting strong capital efficiency over the period..

3B Blackbio DX Ltd's latest EBIT is Rs. 46.55 Cr, surpassing the average EBIT of Rs. 30.39 Cr over the 5 years..